Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Change in Accured Expenses (2016 - 2018)

Ani Pharmaceuticals (ANIP) has disclosed Change in Accured Expenses for 9 consecutive years, with $1.0 million as the latest value for Q3 2018.

  • Quarterly Change in Accured Expenses fell 43.14% to $1.0 million in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $174000.0 through Sep 2018, up 74.0% year-over-year, with the annual reading at $644000.0 for FY2017, 31.49% down from the prior year.
  • Change in Accured Expenses hit $1.0 million in Q3 2018 for Ani Pharmaceuticals, up from -$749000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $1.8 million in Q3 2017 to a low of -$1.9 million in Q4 2015.
  • Historically, Change in Accured Expenses has averaged $171473.7 across 5 years, with a median of $143000.0 in 2014.
  • Biggest five-year swings in Change in Accured Expenses: crashed 523.08% in 2015 and later skyrocketed 45125.0% in 2017.
  • Year by year, Change in Accured Expenses stood at -$630000.0 in 2014, then crashed by 198.57% to -$1.9 million in 2015, then rose by 8.88% to -$1.7 million in 2016, then skyrocketed by 31.74% to -$1.2 million in 2017, then skyrocketed by 187.52% to $1.0 million in 2018.
  • Business Quant data shows Change in Accured Expenses for ANIP at $1.0 million in Q3 2018, -$749000.0 in Q2 2018, and $1.1 million in Q1 2018.